Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
has happened: its pivotal Phase 3 obesity trial, TRIUMPH-1, reported topline results on May 21, 2026 (28.3% average weight loss at 80 weeks) and is now marked complete on ClinicalTrials.gov, followed by TRIUMPH-2 and TRIUMPH-3 on July 23, 2026
Epinephrine is only indicated for life-threatening anaphylaxis or throat swelling
The Beso Wellness Weight Loss Protocol We emphasize a holistic approach
The study is small and the design has limitations, but the mechanistic pathway (AMPK-PFKFB3 activation shifting chondrocyte metabolism) is coherent with everything we know about these drugs
PMID 35355921
US$ 24.68
US$ 20.41
US$ 25.25
US$ 27.10
US$ 27.54
US$ 26.46
US$ 27.37
US$ 22.24
US$ 27.21
US$ 28.83
